Tozasertib
Appearance
| Names | |
|---|---|
| Preferred IUPAC name
N-[4-({4-(4-Methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl}sulfanyl)phenyl]cyclopropanecarboxamide | |
| Identifiers | |
3D model (JSmol) |
|
| ChemSpider | |
| KEGG | |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C23H28N8OS | |
| Molar mass | 464.59 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Tozasertib (VX-680) is an aurora kinase inhibitor.[1]
References
[edit]- ↑ Martens, Sofie; Goossens, Vera; Devisscher, Lars; Hofmans, Sam; Claeys, Polien; Vuylsteke, Marnik; Takahashi, Nozomi; Augustyns, Koen; Vandenabeele, Peter (2018-02-12). "RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)". Cell Death & Disease. 9 (2). Nature Publishing Group: 211. doi:10.1038/s41419-017-0245-7. ISSN 2041-4889. PMC 5833749.
